FindTrial
Sign In

Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port

Study of ethanol lock therapy & antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port - Study of ethanol lock therapy & antimicrobial lock therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022982
Enrollment
45
Registered
2016-08-01
Start date
2016-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Case of catheter-related bloodstream infection in totally implantable central venous port

Interventions

70% ethanol lock therapy (7 days) Antimicribial lock therapy (7-14 days) Systemic antimicrobial therapy (14-21 days)

Sponsors

Division of Gastrointestinal Surgery, Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent home parenteral nutrition by totally implantable central venous port. 2. fever more than 38.0 degree. 3. catheter-related bloodstream infection is suspected. 4. No severe complication by sepsis. General condition is good. 5. No allergy for antimicrobial drugs or ethanol which will be used in this study. 6. Silicine catheter was implanted

Exclusion criteria

Exclusion criteria: 1.Patients with severe sepsis 2.Patients who underwent lock therapy for bacterial infection within 3 months 3.Patients who underwent lock therapy for fungal infection 4.Patients with pregnancy 5. Patients who doctors regarded as inadequate to participate this study.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.—

Secondary

MeasureTime frame
To evaluate the safety of antimicrobial lock therapy for catheter-related bloodstream infection in totally implantable central venous port.—

Countries

Japan

Contacts

Public ContactKazuhiro Watanabe

Tohoku University Hospital Gastrointestinal Surgery

k-wata@surg1.med.tohoku.ac.jp022-717-7205

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026